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ABSTRACT
In total, 201 a-haemolytic Escherichia coli isolates from various clinical materials (urine samples and
vaginal and rectal swabs) were examined by PCR for the presence of genes for the virulence factors
a-haemolysin (hly), cytotoxic necrotising factor type 1 (cnf1), P-ﬁmbriae (pap), S ⁄ F1C-ﬁmbriae (sfa ⁄ foc),
aerobactin (aer) and aﬁmbrial adhesin (afaI). Among vaginal isolates, 96% were positive for cnf1,
compared with 80% of urine strains (p 0.02) and 63% of rectal strains (p 0.0001). Similarly, sfa ⁄ foc-
speciﬁc DNA sequences were found in 97% of vaginal isolates compared with 75% of rectal strains
(p 0.004). The afa1 and aer genes were associated more with rectal a-haemolytic E. coli strains than with
extra-intestinal isolates. The results suggested that CNF1 and ⁄ or S ⁄F1C-ﬁmbriae contribute to
colonisation and persistence of a-haemolytic E. coli strains in the vaginal environment.
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INTRODUCTION
Escherichia coli is able to colonise both the intestinal
and extra-intestinal environments in humans [1].
A balanced relationship exists between the human
immune system and strains of E. coli, which
normally allows them to occupy the host without
causing illness. However, in some speciﬁc circum-
stances (e.g., immediate immune deﬁciency or
because of individual host susceptibility), these
apparent commensals may cause diarrhoea or
extra-intestinal infections [2]. Newborns, the el-
derly, cancer patients and patients with transplan-
ted organs are the most endangered groups [3,4].
The ability of E. coli strains to cause an illness is
inﬂuenced by the carriage of virulence factors [5].
For instance, urinary tract infection in non-
immunocompromised adult women is often asso-
ciated with E. coli strains producing multiple
virulence factors [6]. These include tissue-speciﬁc
adhesins, toxins, siderophores, etc.
One such virulence factor is a-haemolysin
(HlyA), which is associated with both intestinal
and extra-intestinal infections [7]. HlyA is pro-
duced by most haemolytic E. coli strains isolated
from clinical material [8]. HlyA is a member of the
RTX toxin family, on the basis of a common
nonapeptide repeat in the C-terminal part of the
molecule [9]. It is known that a-haemolysin acts
on a wide range of host cells, such as the
erythrocytes of warm-blooded animals and ﬁsh,
chicken embryo ﬁbroblasts, mouse ﬁbroblasts,
monocytes, polymorphonuclear leukocytes and
macrophages [10]. E. coli strains with increased
production of a-haemolysin have also been found
to be more serum-resistant than non-haemolytic
strains or strains with reduced production of
a-haemolysin [11].
It is believed that the persistence of a-haemo-
lytic E. coli strains in the host may be a reason for
the emergence of intestinal or extra-intestinal
infections, and for their recurrence. The faecal
ﬂora is a reservoir for more virulent E. coli strains,
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but the vaginal environment is also colonised by
E. coli [12]. Hence, in this study we searched for
differences (if any) in the distribution of virulence
factors associated with a-haemolysin in E. coli
isolates from various clinical sites. The distribu-
tion of hly, cnf1, afa1, aer, sfa ⁄ foc and pap virulence
genes was examined in haemolytic E. coli strains
isolated from vaginal and rectal swabs and urine
specimens.
MATERIALS AND METHODS
Clinical isolates of E. coli
In total, 201 a-haemolytic E. coli strains were collected in this
study. Strains were isolated from various clinical specimens by
standard bacteriological methods during the period 1993–2002
in our university hospital. Of 201 E. coli strains, 71 were
isolated from the urine specimens of patients with community-
acquired urinary tract infections, of which 24 strains were from
patients with pyelonephritis, 23 were from cystitis patients,
and 24 were from patients with signiﬁcant asymptomatic
bacteriuria (> 105 CFU ⁄mL). Vaginal strains comprised 71
genital tract (cervix or vagina) isolates obtained from adult
women with either various types of genital tract infections (24
isolates), or pre-cancer or cancer of any part of the genital tract
(22), or from healthy pregnant women (25). Rectal strains
(n = 59) were isolated from the rectal swabs of children aged
£ 1 year with a diagnosis of gastroenteritis (13 isolates), or with
other diagnoses, e.g., respiratory tract infection, sepsis or
nutritional deﬁcit (35), or children without any pathological
symptoms (11). E. coli strains EB28 (hly+, aer+, cnf1+, sfa+ and
pap+), KS52 (afa+) and C600 rif– (negative for all detected
virulence factors) were used as positive and negative controls
in PCR detection.
Detection of a-haemolysin
E. coli strains were tested for the production of a haemolytic
phenotype on blood agar plates (Blood Agar Base number 2;
Oxoid, Basingstoke, UK) containing deﬁbrinated sheep eryth-
rocytes 5% v ⁄v. Production of haemolysis was read after
overnight incubation at 37C [13].
Bacterial cultures and DNA extraction
E. coli strains were cultivated on blood agar or in Luria–Bertani
broth overnight at 37C. Bacterial cells were disrupted by rapid
lysis as described previously [14], and the lysate supernatant
was used as a DNA template for PCR assays.
PCR detection of speciﬁc gene sequences
Ampliﬁcation of cnf1-speciﬁc sequences (543-bp product) was
performed as described previously [14], using primers CNF1-
A (5¢-GAACTTATTAAGGATAGT-3¢) and CNF1-B (5¢-CAT-
TATTTATAACGCTG-3¢) in a total volume of 50 lL containing
1 lL DNA extract, 900 ng each of the cnf1-speciﬁc primers,
1.5 mM MgCl2, 0.2 mM each dNTP and 1 U Taq Platinum
polymerase (Gibco BRL Life Technologies, Rockville, MD,
USA). The published ampliﬁcation protocol was slightly
modiﬁed and comprised 94C for 2 min, followed by 33 cycles
of 94C for 1 min, 55C for 1 min and 72C for 1 min, with a
ﬁnal extension at 72C for 2 min.
PCR detection of pap-speciﬁc gene sequences (328-bp
product) was performed with primers pap1 (5¢-GACG
GCTGTACTGCAGGGTGTGGCG-3¢) and pap2 (5¢- ATATCC
TTTCTGCAGGGAT GCAATA), selected from the papC gene
sequence, 1 lL of DNA extract, 1.5 mM MgCl2, 0.2 mM each
dNTP and 0.5 U Taq Platinum polymerase. PCR was per-
formed at 94C for 1 min, followed by 30 cycles of 94C for
1 min, 65C for 1 min and 72C for 1 min, with a ﬁnal
extension at 72C for 2 min [15].
All bacterial strains were also retested by multiplex PCR. A
total volume of 50 lL contained 20 pmol each of pap3 (5¢-GCA
ACAGCAACGCTGGTTGCATCAT-3¢) and pap4 (5¢-AGAGA
GAGCCACTCTTATACGGACA-3¢), giving a 328-bp product;
sfa1 (5¢-CTCCGGAGAACTGGGTGCATCTTAC-3¢) and sfa2
(5¢-CGGAGGAGTAATTACAAACCTGGCA-3¢), giving a 410-bp
product; afa1 (5¢-GCTGGGCAGCAAACTGATAACTCTC-3¢)
and afa2 (5¢-CATCAAGCTGTTTGTTCGTCCGCCG-3¢), giving
a 750-bp product; aer1 (5¢-TACCGGATTGTCATATGCAGA
CCGT-3¢) and aer2 (5¢-AATATCTTCCTCCAGTCCGGAGA
AG-3¢), giving a 602-bp product; cnf1 (5¢-AAGATGGAGTT
TCCTATGCAGGAG-3¢) and cnf2 (5¢-CATTCAGAGTCCTGCC
CTCATTATT-3¢), giving a 498-bp product; and 30 pmol of
hly1 (5¢-AACAAGGATAAGCACTGTTCTGGCT-3¢) and hly2
(5¢-ACCATATAAGCGGTCATTCCCGTCA-3¢), giving a 1177-
bp product. In addition, each reaction contained 2.3 mM
MgCl2, 0.2 mM each dNTP and 2 U Taq Platinum polymerase.
PCR was for 30 cycles, each consisting of 95C for 1 min, 60C
for 30 s (incrementing by 1C after every ﬁve cycles to 65C)
and 72C for 3 min, with a ﬁnal extension at 72C for 7 min
(slightly modiﬁed) [16].
Following PCR, aliquots (10 lL) of the ﬁnal reaction
mixtures were electrophoresed through agarose 2% w ⁄v gels
for 45 min at 80 V. Ampliﬁed DNA fragments were visualised
by UV ﬂuorescence after staining with ethidium bromide.
Statistics
Statistical analysis was performed by means of the Pearson’s v2
test. A p value of < 0.05 was considered to be signiﬁcant.
RESULTS
Detection of virulence factors
The hly gene was detected in 200 E. coli isolates
with a haemolytic phenotype. One strain investi-
gated in this study was phenotypically
non-haemolytic, but was positive by PCR for
hly, cnf1, pap and sfa. In contrast, two haemolytic
E. coli strains (one vaginal and one rectal isolate)
were hly-negative, and were excluded from this
study. PCR detection of cnf1 showed a 100%
correlation between the results of single PCR and
multiplex PCR. Detection of papC and papEF in
multiplex PCRs also showed 100% correlation in
the population of 201 a-haemolytic strains.
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Table 1 shows the frequency of detection of
different virulence factor genes. The cnf1, pap and
sfa ⁄ foc genes were found to be associated closely
with a-haemolytic strains, with overall ﬁgures of
86% positive for pap, 81% for cnf1, and 87% for
sfa ⁄ foc. Aerobactin genes were found less fre-
quently (59%) than cnfI, pap and sfa genes.
Interestingly, aer-positive E. coli strains were
detected more frequently among a-haemolytic
rectal isolates (76%) than among urine (53%;
p 0.01) or vaginal isolates (49%; p 0.003). Only
5% of isolates (two urinary tract isolates and eight
rectal isolates) were positive for afa1.
Table 2 shows the statistically signiﬁcant
differences between the different groups of iso-
lates.
Association of detected virulence factors
Table 3 shows the number of strains with differ-
ent genotype combinations. Sixteen combinations
of the genes were detected in this study. Most
combinations were found among both urine and
rectal E. coli isolates (14 and 13, respectively).
There was less variation in the combinations
among vaginal isolates, with only ﬁve combina-
tions detected (Table 3). The most prevalent
combination, found in 69% of the a-haemolytic
E. coli isolates, was cnf1, pap and sfa ⁄ foc (with or
without aer). This combination was especially
common among extra-intestinal isolates, being
found in 82% of vaginal and 70% of urine isolates
(p 0.0004 and 0.04, respectively, when compared
to the frequency among rectal isolates). The afa
gene was usually associated with pap (80%) and
aer (80%). No afa-positive E. coli isolates carrying
sfa and ⁄ or cnf1 were found.
DISCUSSION
As in previous studies [6,17], the cnf1, pap and
sfa ⁄ foc genes were found frequently (80–90%)
with hly in a single strain. The results also
conﬁrmed previous ﬁndings that afa gene
sequences are generally not found with sfa and ⁄ or
cnf1, but are associated positively with pap and aer
(80% for both genes) [6,15].
Statistical analysis revealed an increased occur-
rence of cnf1 and sfa ⁄ foc in E. coli isolates from
Table 1. Occurrence of virulence factor genes among
a-haemolytic clinical Escherichia coli isolates
Virulence factor gene
Number of positive isolates from each source
Urine (n = 71) Vaginal (n = 71) Rectal (n = 59)
cnf1 57 (80%) 68 (96%) 37 (63%)
pap 63 (89%) 59 (83%) 50 (85%)
sfa 61 (86%) 69 (97%) 44 (75%)
afaI 2 (3%) 0 8 (13.5%)
aer 38 (53%) 35 (49%) 45 (76%)
Table 2. Statistically signiﬁcant differences in the occur-
rence of virulence factors between different groups of
Escherichia coli isolates
Virulence factor gene
p Values for compared groups of isolates
Rectal vs. urine Rectal vs. vaginal Vaginal vs. urine
cnf1 0.07 < 0.0001 0.02
pap NS NS NS
sfa NS 0.0004 0.03
afaI 0.05 0.004 NS
aer 0.01 0.003 NS
NS, not signiﬁcant.
Table 3. Occurrence of virulence
combinations among clinical isolates
(VF-virulence factor)
Virulence factor combination Number of isolates from each source
cnf1 pap sfa afaI aer Urine (n = 71) Vaginal (n = 71) Rectal (n = 59)
+ + + – + 26 (36.6%) 32 (45.1%) 24 (40.7%)
+ + + – – 24 (33.8%) 26 (36.6%) 7 (11.9%)
+ – + – – 2 (2.8%) 10 (14.1%) 4 (6.8%)
+ + – – + 1 (1.4%) 0 1 (1.7%)
+ + – – – 2 (2.8%) 0 1 (1.7%)
+ – + – + 2 (2.8%) 0 0
– + + – + 4 (5.6%) 1 (1.4%) 7 (11.9%)
– + + – – 2 (2.8%) 0 1 (1.7%)
– + – – + 2 (2.8%) 0 3 (5.1%)
– – + – – 1 (1.4%) 0 0
– – + – + 0 0 1 (1.7%)
– – – – + 2 (2.8%) 2 (2.8%) 2 (3.4%)
– – – – – 1 (1.4%) 0 0
– + – + + 1 (1.4%) 0 5 (8.5%)
– – – + + 0 0 2 (3.4%)
– + – + – 1 (1.4%) 0 1 (1.7%)
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vaginal swabs, compared to isolates from urine or
rectal swabs. Necrotoxigenic E. coli strains in the
vagina (i.e., cnf1+) have also been reported by
other authors using a phenotypic method [18,19].
This ﬁnding may be signiﬁcant for three reasons.
First, S-ﬁmbriae are known to comprise a key
virulence factor in the pathogenesis of neonatal
meningitis caused by E. coli. Therefore, persist-
ence of S-ﬁmbriated a-haemolytic E. coli strains in
the vagina of pregnant women may expose
neonates to a higher risk of infection. The risk
associated with vaginal carriage of a-haemolytic
strains of E. coli was also emphasised by Czirok
et al. [20] in an investigation of virulence factors in
E. coli isolates from the cerebrospinal ﬂuid of
neonates with meningitis. Second, E. coli is the
most frequent pathogen isolated from bacterial
prostatitis patients [21]. Several authors have
observed an increased proportion of necrotoxi-
genic E. coli strains from patients with bacterial
prostatitis [22,23]. Therefore, vaginal carriage of
necrotoxigenic E. coli strains could expose sexual
partners to a risk of prostatic infection. Third,
women often suffer from an enhanced suscepti-
bility to recurrent urinary and genital tract infec-
tions in association with uropathogenic E. coli
strains [24].
Rectal a-haemolytic E. coli isolates showed an
increased incidence of aer (76%; p 0.01 com-
pared to 52% for urine isolates; p 0.003 com-
pared to 49% for vaginal isolates). This ﬁnding
suggests that aerobactin is advantageous for the
survival of a-haemolytic E. coli strains in the
gut. The precise role of aer in intestinal carriage
of uropathogenic E. coli strains or those associ-
ated with diarrhoea in children, remains to be
determined. Diffusely adherent (i.e., afa-positive)
E. coli strains have been described in association
with more severe forms of urinary tract infec-
tion [25]. However, uropathogenic afa-positive
E. coli strains are usually non-haemolytic
[6,17,26]. Other authors have reported the fre-
quent occurrence (31%) of afa-positive E. coli
strains in association with diarrhoea [27,28].
Considering the results of the present study,
together with those of other authors, it can be
concluded that a-haemolytic afa-positive E. coli
strains are probably found more frequently in
the intestinal tract, while uropathogenic afa-
positive E. coli strains are usually non-hae-
molytic.
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